114 related articles for article (PubMed ID: 18019188)
1. Tularemia vaccines - an overview.
McMurry JA; Moise L; Gregory SH; De Groot AS
Med Health R I; 2007 Oct; 90(10):311-4. PubMed ID: 18019188
[TBL] [Abstract][Full Text] [Related]
2. Immunological markers that correlate with protection immunity against tularemia infection.
Firstova VV; Mokrievich AN; Pavlov VM; Gorbatov AA; Kombarova TI; Biketov SF; Dyatlov IA
Adv Exp Med Biol; 2014; 808():15-23. PubMed ID: 24595607
[TBL] [Abstract][Full Text] [Related]
3. Vaccination strategies for Francisella tularensis.
Isherwood KE; Titball RW; Davies DH; Felgner PL; Morrow WJ
Adv Drug Deliv Rev; 2005 Jun; 57(9):1403-14. PubMed ID: 15919131
[TBL] [Abstract][Full Text] [Related]
4. Vaccines against Francisella tularensis.
Wayne Conlan J; Oyston PC
Ann N Y Acad Sci; 2007 Jun; 1105():325-50. PubMed ID: 17395730
[TBL] [Abstract][Full Text] [Related]
5. Francisella tularensis--a model for studies of the immune response to intracellular bacteria in man.
Tärnvik A; Eriksson M; Sandström G; Sjöstedt A
Immunology; 1992 Jul; 76(3):349-54. PubMed ID: 1526645
[No Abstract] [Full Text] [Related]
6. Natural killer and CD8 T cells dominate the response by human peripheral blood mononuclear cells to inactivated Francisella tularensis live vaccine strain.
Gosselin EJ; Gosselin DR; Lotz SA
Hum Immunol; 2005 Oct; 66(10):1039-49. PubMed ID: 16386645
[TBL] [Abstract][Full Text] [Related]
7. Diversity of Francisella tularensis Schu4 antigens recognized by T lymphocytes after natural infections in humans: identification of candidate epitopes for inclusion in a rationally designed tularemia vaccine.
McMurry JA; Gregory SH; Moise L; Rivera D; Buus S; De Groot AS
Vaccine; 2007 Apr; 25(16):3179-91. PubMed ID: 17291638
[TBL] [Abstract][Full Text] [Related]
8. [Study of the immunizing effect of the virulent Tularemia strain treated by streptomycin].
Brikman DI
Antibiotiki; 1971 Sep; 16(9):827-31. PubMed ID: 5139456
[No Abstract] [Full Text] [Related]
9. Francisella tularensis vaccines.
Griffin KF; Oyston PC; Titball RW
FEMS Immunol Med Microbiol; 2007 Apr; 49(3):315-23. PubMed ID: 17316369
[TBL] [Abstract][Full Text] [Related]
10. Dominance of human innate immune responses in primary Francisella tularensis live vaccine strain vaccination.
Fuller CL; Brittingham KC; Hepburn MJ; Martin JW; Petitt PL; Pittman PR; Bavari S
J Allergy Clin Immunol; 2006 May; 117(5):1186-8. PubMed ID: 16675351
[No Abstract] [Full Text] [Related]
11. Francisella tularensis vaccines.
Oyston PC
Vaccine; 2009 Nov; 27 Suppl 4():D48-51. PubMed ID: 19837286
[TBL] [Abstract][Full Text] [Related]
12. The membrane form of tumor necrosis factor is sufficient to mediate partial innate immunity to Francisella tularensis live vaccine strain.
Cowley SC; Goldberg MF; Ho JA; Elkins KL
J Infect Dis; 2008 Jul; 198(2):284-92. PubMed ID: 18593295
[TBL] [Abstract][Full Text] [Related]
13. Progress, challenges, and opportunities in Francisella vaccine development.
Elkins KL; Kurtz SL; De Pascalis R
Expert Rev Vaccines; 2016 Sep; 15(9):1183-96. PubMed ID: 27010448
[TBL] [Abstract][Full Text] [Related]
14. Macrophage activating factors produced in the course of murine tularemia: effect on multiplication of microbes.
Kovarova H; Marcela A; Stulik J
Arch Immunol Ther Exp (Warsz); 1992; 40(3-4):183-90. PubMed ID: 1300982
[TBL] [Abstract][Full Text] [Related]
15. Protection afforded against aerosol challenge by systemic immunisation with inactivated Francisella tularensis live vaccine strain (LVS).
Eyles JE; Hartley MG; Laws TR; Oyston PC; Griffin KF; Titball RW
Microb Pathog; 2008 Feb; 44(2):164-8. PubMed ID: 17904793
[TBL] [Abstract][Full Text] [Related]
16. Francisella tularensis-induced in vitro gamma interferon, tumor necrosis factor alpha, and interleukin 2 responses appear within 2 weeks of tularemia vaccination in human beings.
Karttunen R; Surcel HM; Andersson G; Ekre HP; Herva E
J Clin Microbiol; 1991 Apr; 29(4):753-6. PubMed ID: 1909711
[TBL] [Abstract][Full Text] [Related]
17. Biosafety and selectable markers.
Titball RW; Sjostedt A; Pavelka MS; Nano FE
Ann N Y Acad Sci; 2007 Jun; 1105():405-17. PubMed ID: 17416926
[TBL] [Abstract][Full Text] [Related]
18. Development of Francisella tularensis antigen responses measured as T-lymphocyte proliferation and cytokine production (tumor necrosis factor alpha, gamma interferon, and interleukin-2 and -4) during human tularemia.
Surcel HM; Syrjälä H; Karttunen R; Tapaninaho S; Herva E
Infect Immun; 1991 Jun; 59(6):1948-53. PubMed ID: 1674737
[TBL] [Abstract][Full Text] [Related]
19. [ROLE OF VARIOUS ANTIGENIC PREPARATIONS OF FRANCISELLA TULARENSIS IN FORMATION OF ALLERGY REACTION IN HUMANS AND ANIMALS].
Onoprienko NN; Aronova NV; Pavlovich NV
Zh Mikrobiol Epidemiol Immunobiol; 2016; (1):22-9. PubMed ID: 27029112
[TBL] [Abstract][Full Text] [Related]
20. [Tularemia vaccine strain is a potential vector].
Pavlov VM; Mokrievich AN; Noskov AN; Urakov NN
Vestn Ross Akad Med Nauk; 1997; (6):30-2. PubMed ID: 9289276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
